Document Detail


Is surgery the gold standard in the treatment of obstructive hypertrophic cardiomyopathy?
MedLine Citation:
PMID:  23027595     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: Hypertrophic cardiomyopathy is a complex and relatively common genetic cardiac disease and has been the subject of intensive scrutiny and investigation for over 40 years. The aim of this non-randomized cohort study was to compare subjective and objective outcomes in hypertrophic cardiomyopathy patients undergoing drug therapy, surgical myotomy-myectomy, dual-chamber pacing and alcohol septal ablation.
METHODS: We examined 194 patients: 103 with non-obstructive hypertrophic cardiomyopathy and 91 with obstructive hypertrophic cardiomyopathy. All the patients with a non-obstructive form were on drug therapy. Ninety-one consecutive patients with drug-refractory obstructive hypertrophic cardiomyopathy were treated invasively. Dual-chamber pacemaker implantation was performed for 49 patients with previous positive temporary pacing test (Group 1). In 28 patients with massive left ventricle hypertrophy and obliteration of its cavities, extensive myotomy-myectomy was performed (Group 2). In 14 patients with midventricular obstruction and appropriate coronary anatomy, alcohol septal ablation was performed (Group 3).
RESULTS: The peak left ventricle outflow tract gradient was 84.1 ± 15.2 mmHg in Group 1, 113.3 ± 14.9 mmHg in Group 2 and 97.5 ± 8.9 mmHg in Group 3. Dual-chamber pacing in Group 1 with optimal atrio-ventricular delay (85-180 ms for atrium pacing and 45-120 ms for atrial sensing) leads to dramatic decreases in left ventricle outflow tract gradient to 17.6 ± 11.8 mmHg and degree of mitral regurgitation. After extensive myectomy in Group 2, we observed a reduction of left ventricle outflow tract gradient to 17.3 ± 10.2 mmHg. Septal alcohol ablation in Group 3 leads to a left ventricle outflow tract gradient decrease from 97.5 ± 8.9 to 25.3 ± 5.8 mmHg.
CONCLUSIONS: Surgical myectomy, dual-chamber pacing and alcohol septal ablation are equally effective in reducing obstruction in case of correct indications. Dual-chamber pacing is indicated in functional reversible states characterized by excitation delay. Alcohol septal ablation is preferable in cases with midventricular obstruction and appropriate coronary anatomy. Surgical methods are indicated in anatomical irreversible changes and remain the gold standard for obstructive hypertrophic cardiomyopathy treatment.
Authors:
Gennady Knyshov; Vasyl Lazoryshynets; Kostyantyn Rudenko; Borys Kravchuk; Vyacheslav Beshlyaga; Valery Zalevsky; Olga Rasputnyak; Bogdan Batsak
Related Documents :
24368725 - The effect of exogenous creatine phosphate on myocardial injury after percutaneous coro...
1879205 - Myocardial infarction due to isolated left circumflex or right coronary artery occlusion.
10549905 - Associations between different status of myocardial ischemia and ischemia-related negat...
25090305 - Assessment of coronary ischaemia by myocardial perfusion dipyridamole stress technetium...
18646515 - Dynamic left ventricular outflow tract obstruction without basal septal hypertrophy, ca...
17826645 - Urinary b-type natriuretic peptide levels in the diagnosis and prognosis of heart failure.
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2012-09-30
Journal Detail:
Title:  Interactive cardiovascular and thoracic surgery     Volume:  16     ISSN:  1569-9285     ISO Abbreviation:  Interact Cardiovasc Thorac Surg     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2012-12-18     Completed Date:  2013-05-31     Revised Date:  2014-01-09    
Medline Journal Info:
Nlm Unique ID:  101158399     Medline TA:  Interact Cardiovasc Thorac Surg     Country:  England    
Other Details:
Languages:  eng     Pagination:  5-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Ablation Techniques* / adverse effects,  standards
Adolescent
Adult
Cardiac Pacing, Artificial* / adverse effects,  standards
Cardiac Surgical Procedures* / adverse effects,  standards
Cardiomyopathy, Hypertrophic / diagnosis,  physiopathology,  surgery,  therapy*
Cardiovascular Agents / therapeutic use
Disease Progression
Ethanol / administration & dosage
Female
Humans
Male
Middle Aged
Patient Selection
Recovery of Function
Retrospective Studies
Stroke Volume
Time Factors
Treatment Outcome
Ventricular Function, Left
Ventricular Pressure
Young Adult
Chemical
Reg. No./Substance:
0/Cardiovascular Agents; 3K9958V90M/Ethanol
Comments/Corrections
Comment In:
Interact Cardiovasc Thorac Surg. 2013 Jan;16(1):9-10   [PMID:  23248209 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ultra-Low Voltage, OTFT-Based Sensor for Label-Free DNA Detection.
Next Document:  Preservation versus non-preservation of mitral valve apparatus during mitral valve replacement: a me...